Literature DB >> 16000408

Inhibition of IFN-alpha signaling by a PKC- and protein tyrosine phosphatase SHP-2-dependent pathway.

Zhimei Du1, Yuhong Shen, Wentian Yang, Ingrid Mecklenbrauker, Benjamin G Neel, Lionel B Ivashkiv.   

Abstract

Cytokine signaling by the Jak-STAT pathway is subject to complex negative regulation that limits the amplitude and duration of signal transduction. Inhibition of signaling also mediates negative crosstalk, whereby factors with opposing biological activities crossinhibit each other's function. Here, we investigated a rapidly inducible mechanism that inhibited Jak-STAT activation by IFN-alpha, a cytokine that is important for antiviral responses, growth control, and modulation of immune responses. IFN-alpha-induced signaling and gene activation were inhibited by ligation of Fc receptors and Toll-like receptors 7 and 8 in a PKCbeta-dependent manner. Neither PKCbeta nor PKCdelta influenced responses of cells treated with IFN-alpha alone. Inhibition of IFN-alpha signaling correlated with suppression of IFN-alpha-dependent antiviral responses. PKC-mediated inhibition did not require de novo gene expression but involved the recruitment of PKCbeta to the IFN-alpha receptor and interaction with protein tyrosine phosphatase SHP-2, resulting in augmented phosphatase activity. PKC-mediated inhibition of IFN-alpha signaling was abolished in SHP-2-deficient cells, demonstrating a pivotal role for SHP-2 in this inhibitory pathway. Together, our data describe a rapidly inducible, direct mechanism of inhibition of Jak-STAT signaling mediated by a PKCbeta-SHP-2 signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16000408      PMCID: PMC1177356          DOI: 10.1073/pnas.0408854102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  45 in total

1.  PKC controls HGF-dependent c-Met traffic, signalling and cell migration.

Authors:  Stéphanie Kermorgant; Daniel Zicha; Peter J Parker
Journal:  EMBO J       Date:  2004-09-23       Impact factor: 11.598

2.  Inhibition of alpha interferon but not gamma interferon signal transduction by phorbol esters is mediated by a tyrosine phosphatase.

Authors:  E Petricoin; M David; K Igarashi; C Benjamin; L Ling; S Goelz; D S Finbloom; A C Larner
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

Review 3.  Interferons and their actions.

Authors:  S Pestka; J A Langer; K C Zoon; C E Samuel
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

Review 4.  Interferons: laboratory to clinic investigations.

Authors:  L C Platanias
Journal:  Curr Opin Oncol       Date:  1995-11       Impact factor: 3.645

5.  Immunodeficiency in protein kinase cbeta-deficient mice.

Authors:  M Leitges; C Schmedt; R Guinamard; J Davoust; S Schaal; S Stabel; A Tarakhovsky
Journal:  Science       Date:  1996-08-09       Impact factor: 47.728

6.  The SH2 domain-containing tyrosine phosphatase PTP1D is required for interferon alpha/beta-induced gene expression.

Authors:  M David; G Zhou; R Pine; J E Dixon; A C Larner
Journal:  J Biol Chem       Date:  1996-07-05       Impact factor: 5.157

Review 7.  Hepatitis C treatment update.

Authors:  Brian L Pearlman
Journal:  Am J Med       Date:  2004-09-01       Impact factor: 4.965

Review 8.  Cytokine therapeutics: lessons from interferon alpha.

Authors:  J U Gutterman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

9.  Dual myristylation and palmitylation of Src family member p59fyn affects subcellular localization.

Authors:  L Alland; S M Peseckis; R E Atherton; L Berthiaume; M D Resh
Journal:  J Biol Chem       Date:  1994-06-17       Impact factor: 5.157

10.  Interleukin 12 (IL-12) induces tyrosine phosphorylation of JAK2 and TYK2: differential use of Janus family tyrosine kinases by IL-2 and IL-12.

Authors:  C M Bacon; D W McVicar; J R Ortaldo; R C Rees; J J O'Shea; J A Johnston
Journal:  J Exp Med       Date:  1995-01-01       Impact factor: 14.307

View more
  24 in total

1.  Ligation of CD180 inhibits IFN-α signaling in a Lyn-PI3K-BTK-dependent manner in B cells.

Authors:  Ming You; Guanjun Dong; Fanlin Li; Feiya Ma; Jing Ren; Yujun Xu; Huimin Yue; Ruijing Tang; Deshan Ren; Yayi Hou
Journal:  Cell Mol Immunol       Date:  2015-08-17       Impact factor: 11.530

Review 2.  Integration of cytokine and heterologous receptor signaling pathways.

Authors:  Jelena S Bezbradica; Ruslan Medzhitov
Journal:  Nat Immunol       Date:  2009-03-19       Impact factor: 25.606

Review 3.  Protein tyrosine phosphatases in the JAK/STAT pathway.

Authors:  Dan Xu; Cheng-Kui Qu
Journal:  Front Biosci       Date:  2008-05-01

4.  ITAM-coupled receptors inhibit IFNAR signaling and alter macrophage responses to TLR4 and Listeria monocytogenes.

Authors:  Linda Huynh; Lu Wang; Chao Shi; Kyung-Hyun Park-Min; Lionel B Ivashkiv
Journal:  J Immunol       Date:  2012-02-24       Impact factor: 5.422

5.  A critical role for SHP2 in STAT5 activation and growth factor-mediated proliferation, survival, and differentiation of human CD34+ cells.

Authors:  Liang Li; Hardik Modi; Tinisha McDonald; John Rossi; Jiing-Kuan Yee; Ravi Bhatia
Journal:  Blood       Date:  2011-06-13       Impact factor: 22.113

6.  Increased expression of tyrosine phosphatase SHP-2 in Helicobacter pylori-infected gastric cancer.

Authors:  Jing Jiang; Mei-Shan Jin; Fei Kong; Yin-Ping Wang; Zhi-Fang Jia; Dong-Hui Cao; Hong-Xi Ma; Jian Suo; Xue-Yuan Cao
Journal:  World J Gastroenterol       Date:  2013-01-28       Impact factor: 5.742

Review 7.  Cross-regulation of signaling by ITAM-associated receptors.

Authors:  Lionel B Ivashkiv
Journal:  Nat Immunol       Date:  2009-03-19       Impact factor: 25.606

8.  Epstein-Barr virus interferes with the amplification of IFNalpha secretion by activating suppressor of cytokine signaling 3 in primary human monocytes.

Authors:  François Michaud; François Coulombe; Eric Gaudreault; Carine Paquet-Bouchard; Marek Rola-Pleszczynski; Jean Gosselin
Journal:  PLoS One       Date:  2010-07-30       Impact factor: 3.240

Review 9.  A signal-switch hypothesis for cross-regulation of cytokine and TLR signalling pathways.

Authors:  Lionel B Ivashkiv
Journal:  Nat Rev Immunol       Date:  2008-10       Impact factor: 53.106

10.  Human TRIM gene expression in response to interferons.

Authors:  Laetitia Carthagena; Anna Bergamaschi; Joseph M Luna; Annie David; Pradeep D Uchil; Florence Margottin-Goguet; Walther Mothes; Uriel Hazan; Catherine Transy; Gianfranco Pancino; Sébastien Nisole
Journal:  PLoS One       Date:  2009-03-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.